ArticleGlobal public health2025
Organoids at the forefront of global health: accelerated research and ethical implications in the cases of Zika and COVID-19.
Article in Global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Building global research equity through lung organoids: a prerequisite for the next respiratory pandemic.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Bioengineering technologies are increasingly important in global health research, yet their applications beyond vaccines and diagnostics remain underexplored. Our paper examines the role of organoids - advanced stem cell technologies used to model human organs, such as lungs and brains - in the context of infectious disease research. Organoids became crucial during the Zika and COVID-19 outbreaks. These new model systems enabled rapid insights into pathogen behaviour. We analyse how the urgency of Zika and Covid-19 accelerated organoid research, tracing its rise and subsequent slowdown. Our investigation reveals that while organoid technologies experienced a burst of activity during these emergencies, their momentum has waned, with ongoing research predominantly focusing on diseases prevalent in the Global North. We argue that the uneven acceleration and subsequent deceleration of organoid research underscores a critical need for equitable integration of bioengineering in global health priorities, particularly in the context of pandemic preparedness. Our findings advocate for a balanced and inclusive strategy to enhance pandemic preparedness and address global health disparities effectively.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.